These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 24625885)
1. The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer. Xu J Asian J Androl; 2014; 16(4):536-40. PubMed ID: 24625885 [TBL] [Abstract][Full Text] [Related]
2. Defining prostate cancer risk before prostate biopsy. Pal RP; Maitra NU; Mellon JK; Khan MA Urol Oncol; 2013 Nov; 31(8):1408-18. PubMed ID: 22795499 [TBL] [Abstract][Full Text] [Related]
3. Biopsy diagnosis of prostatic cancer--current areas of concern. Feneley MR; Parkinson MC J Clin Pathol; 1997 Apr; 50(4):265-6. PubMed ID: 9215135 [No Abstract] [Full Text] [Related]
4. Management of rising prostate-specific antigen following a negative biopsy. Jones JS Curr Opin Urol; 2010 May; 20(3):198-203. PubMed ID: 20583345 [No Abstract] [Full Text] [Related]
5. [PSA 2010--the beginning of a new era in early detection of prostate cancer]. Börgermann C; Sieverding M; Fornara P; Graefen M; Hammerer P; Semjonow A; Schröder F; Rübben H Urologe A; 2006 Sep; 45 Suppl 4():127-33. PubMed ID: 16941115 [No Abstract] [Full Text] [Related]
6. [Comment on Grond, A., M. Ostermann-Myrau: Benign and malignant diseases of the prostate]. Grond A Versicherungsmedizin; 1995 Apr; 47(2):66-7. PubMed ID: 7539193 [No Abstract] [Full Text] [Related]
7. Novel biomarkers and advanced imaging modalities in the early detection of prostate cancer. Parsons JK J Urol; 2015 Apr; 193(4):1084-5. PubMed ID: 25596362 [No Abstract] [Full Text] [Related]
8. Knowledge, attitude and practice regarding prostate specific antigen (PSA) and prostate biopsy. Nazim SM; Raza SJ; Ather MH J Coll Physicians Surg Pak; 2013 Jul; 23(7):529-30. PubMed ID: 23823969 [No Abstract] [Full Text] [Related]
9. PSA density and early prostate cancer detection. Christensen JG Urology; 1994 Jul; 44(1):150-1. PubMed ID: 7518978 [No Abstract] [Full Text] [Related]
10. [A new marker for prostate cancer is evaluated]. Fath R; Ikinger U Aktuelle Urol; 2004 Sep; 35(5):365-6. PubMed ID: 15383999 [No Abstract] [Full Text] [Related]
14. The Problem Is Not What to Do with Indolent and Harmless Prostate Cancer-The Problem Is How to Avoid Finding These Cancers. Gandaglia G; Briganti A; Fossati N; Salonia A; Mottrie A; Catto J; Montorsi F Eur Urol; 2016 Oct; 70(4):547-548. PubMed ID: 26916048 [TBL] [Abstract][Full Text] [Related]
15. Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL. Lee DH; Nam JK; Park SW; Lee SS; Han JY; Lee SD; Lee JW; Chung MK Yonsei Med J; 2016 May; 57(3):565-71. PubMed ID: 26996553 [TBL] [Abstract][Full Text] [Related]
16. [Early detection of prostatic carcinoma: Is PSA screening suitable?]. Kaulen H Dtsch Med Wochenschr; 2003 May; 128(18):977. PubMed ID: 12755136 [No Abstract] [Full Text] [Related]
17. Legal pitfalls in the diagnosis of prostate cancer. Dunn IB; Kirk D BJU Int; 2000 Aug; 86(3):304-7. PubMed ID: 10930937 [No Abstract] [Full Text] [Related]
18. Prostate cancer with low PSA levels. Glaser AI N Engl J Med; 2004 Oct; 351(17):1802-3. PubMed ID: 15499670 [No Abstract] [Full Text] [Related]
19. PSA scores: should we use a lower threshold? Carter HB Johns Hopkins Med Lett Health After 50; 2004 Oct; 17(8):6. PubMed ID: 15602780 [No Abstract] [Full Text] [Related]
20. [Diagnostic value of tissue and serum prostate specific antigen in prostate cancer]. Medvedev VL Voen Med Zh; 2004 Feb; 325(2):50-4. PubMed ID: 15101295 [No Abstract] [Full Text] [Related] [Next] [New Search]